Elevate is Kemsyn's forward-looking business division committed to women's health and the control of chronic conditions backed by Synokem's legacy, three WHO-GMP compliant production facilities in Haridwar, and the group's sterile-injectable technology with Nitin Lifesciences.
Offer world-class, cutting-edge treatments at affordable, accessible, and still available levels—all with ethics, sustainability, and scientific excellence.
What Elevate Stands For
Chronic Care at Scale
Women's Health First
Quality That You Can Count On
Key Focus Areas
Cardio-Diabetic Management
Clinical focus on women's reproductive health, hormonal equilibrium, and gynecologic well-being, such as therapies for female infertility, HRT, control of ovulation/menstruation, and contraception.
Chronic Care at Scale
Evidence-based cardio-diabetic solutions in anti-hypertensives, cardiology medicines, lipid-lowering medicines, and oral anti-diabetic medicines (fixed and simple dose combinations).
Quality That You Can Count On
End-to-end quality diligence and compliance; each product a promise of quality.
Women's Hormone Therapies
Portfolio for use in infertility, HRT, cycle control, and using contraceptives.
Why Elevate (Backed by the Group)
Manufacturing Strength
Three WHO-GMP Haridwar sites; leadership in sterile-injectables through Nitin Lifesciences (HP & Haryana).
Portfolio Breadth
Kemsyn offers wide coverage across therapeutic classes to enable end-to-end care pathways.
Access & Affordability
Created to bring quality medicines at an economic price and improve patient outcomes.
Scale Ready
Maintaining a portfolio in excess of 300 SKUs to support high-impact, high-volume launches whenever needed.